期刊文献+

临床红细胞规范性输注及有效性分析 被引量:1

Analysis of validity and normative of clinical red blood cell transfusion
原文传递
导出
摘要 目的:调查红细胞输注的规范性和有效性,为临床科学合理用血提供依据。方法:通过调查2011-05-12月全部红细胞输注病例,计算血红蛋白升高值,评价输血有效性。同时回顾性分析红细胞输注的规范性。结果:总计3571份红细胞输注病例,用血量为8136U,其中红细胞输注无效占15.71%,输血指针不符的输注有14.50%并有9.44%的临床输血未作血红蛋白监测。结论:临床红细胞输注存在不合理用血,无效输血,输血前后无评估现象,血制品科学使用有待进一步提高。 Objective:To investigate validity and normative of clinical blood transfusion,provide basis for scientific clinical blood transfusion. Method:Through the ivestigate all red cell transfusion case between 2011.5-2011.12.Calculate the increase value of the Hemoglobin,to evaluate the effect of the red blood cell transfusion. Result:Investigate a total of 3 035 cases of blood transfusion,used 8 136 U red blood cell,in which the ineffective blood transfusion acounted for 15.71%.14.50% of the blood transfusion don't comply with blood transfuion pointer and 9.44% of the clinical blood transfusion without Hemoglobin monitoring as well. Conclusion:There are a lot of clinical transfusion of red cell is not reasonable transfusion,ineffective blood transfusion,don't do clinical monitoring before or after blood transfusion.Scientific use of blood products need to be further improved.
出处 《临床血液学杂志(输血与检验)》 CAS 2013年第3期370-372,共3页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
基金 上海市公共卫生优秀学科带头人培养计划(No:GWDTR201213) 重点学科建设计划(No:12GWZX0202)
关键词 红细胞输注 无效输血 输血规范性 clinical red blood transfusion ineffective transfusion normative blood transfusion
  • 相关文献

参考文献5

二级参考文献16

  • 1吕运来,贠中桥,兰炯采,孙先玲,杨波,张艳艳.红细胞无效输注回顾性初探[J].中国输血杂志,2007,20(3):220-221. 被引量:70
  • 2Eriksson L, Kristensen J, Olsson K, et at. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets: comparison between platelet concentrates derived from pooled huffy coates and apheresis [J]. Vox Sang, 1996, 70(2):69-75.
  • 3Davis K B, Slichter S J, Corash L. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution [J]. Transfusion, 1999, 39 (6): 586-592.
  • 4Heddle N M, Arnold D M, Boye D, et al. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review [ J ]. Transfusion, 2008, 48 (7) : 1447-1458.
  • 5Vamvakas EC, Blajchman MA. Transfusion-related immunomodu- lation (TRIM) : an update. Blood Rev,2007 ,21:327-348.
  • 6Majetschak M. Extracellular ubiquitin: immune modulator and en- dogenous opponent of damage-associated molecular pattern mole- cures. J Leukoc Biol,2010,89 : 1-15.
  • 7Majetschak M, Krehmeier U, Bardenheuer M, et al. Extraeellular ubiquitin inhibits the TNF-alpha response to endotoxin in peripher- al blood mononuclear cells and regulates endotoxin hyporesponsive- ness in critical illness. Blood,2003,101 : 1882-1890.
  • 8Dzik WH,Corwin H,Goodnough LT,et al.Patient safety and blood transfusion:new solutions[J].Transfusion Medicine Reviews,2003,17(3):169-170.
  • 9夏荣,兰炯采.重视红细胞输注无效,提高临床输血效果[J].中国输血杂志,2008,21(1):5-5. 被引量:58
  • 10丁琪,孙先玲,兰炯采,贠中桥,张俊玲,姚富柱,罗广平,吐尔洪,唐朝辉,李聚林.红细胞输注效果影响因素的Logistic回归分析[J].中国输血杂志,2008,21(1):10-12. 被引量:35

共引文献118

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部